NFKB1 and cancer: Discovered in 1986 as a B cell-specific transcription factor [35], the NFκB family are an integral group of inducible transcription factors, expressed across nearly all cell types as the pleiotropic end of multiple signalling pathways, often co-opted in cancer development [36].